Healios KK (HLOSF)
0.9804
-0.01
(-1.31%)
USD |
OTCM |
May 20, 10:05
Healios Free Cash Flow: -19.34M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -19.34M |
| December 31, 2023 | -20.31M |
| September 30, 2023 | -19.68M |
| June 30, 2023 | -24.67M |
| March 31, 2023 | -29.60M |
| December 31, 2022 | -37.29M |
| September 30, 2022 | -46.64M |
| June 30, 2022 | -48.46M |
| March 31, 2022 | -48.89M |
| Date | Value |
|---|---|
| December 31, 2021 | -49.12M |
| September 30, 2021 | -44.73M |
| June 30, 2021 | -43.20M |
| March 31, 2021 | -44.78M |
| December 31, 2020 | -39.89M |
| September 30, 2020 | -36.18M |
| June 30, 2020 | -39.42M |
| March 31, 2020 | -41.53M |
| December 31, 2019 | -45.75M |
Free Cash Flow Range, Past 5 Years
-49.12M
Minimum
Dec 2021
-19.34M
Maximum
Mar 2024
-37.75M
Average
-40.71M
Median
Free Cash Flow Benchmarks
| Takeda Pharmaceutical Co Ltd | 1.633B |
| Nxera Pharma Co Ltd | -49.09M |
| PeptiDream Inc | 6.450M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.144M |
| Cash from Investing (Quarterly) | -2.480M |
| Cash from Financing (Quarterly) | 14.90M |
| Free Cash Flow Per Share (Quarterly) | -0.0501 |
| Free Cash Flow to Equity (Quarterly) | -2.163M |
| Free Cash Flow to Firm (Quarterly) | 5.316M |
| Free Cash Flow Yield | -27.05% |